Posipin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Posipin

Property Description
Active Ingredient Nifedipine
Form Oral preparations (tablets, capsules)
Pharmacological Class Calcium Channel Blocker (CCB)
General Purpose Management of high blood pressure and vascular constriction
Origin Synthetic compound

What Type of Medicine is Posipin?

Posipin is a trade name for the synthetic compound Nifedipine, which is consistently classified as a Calcium Channel Blocker (CCB), primarily intended for oral preparation to manage conditions related to the cardiovascular system. The active substance Nifedipine belongs specifically to the dihydropyridine subgroup of calcium channel blockers, a distinction clinically recognized for its focused effect on vascular smooth muscle relaxation. This classification highlights its primary function in influencing the peripheral vascular system.


Composition and Physical Form

The medication Posipin is a single-active-ingredient product whose therapeutic effect comes solely from Nifedipine, a derivative with the chemical structure C17H18N2O6. Nifedipine is a recognized compound with a defined chemical identity. Posipin is manufactured for systemic administration via the oral route, commonly available as several distinct forms of pharmaceutical preparations, including standard immediate-release capsules or tablets, and specialized extended-release tablets. This range of oral preparations provides options for both rapid and sustained release, essential for the stable management of chronic vascular conditions.


General Purpose: Managing the Cardiovascular System

The overarching purpose of Posipin is to support the management of the cardiovascular system by facilitating the relaxation and widening of arterial walls. The active substance functions as an L-type calcium channel antagonist, which prevents the entry of calcium ions necessary for the contraction of arterial smooth muscle cells. The resulting vasodilation is a key physiological action that decreases the pressure exerted by the blood against the vessel walls, known as peripheral vascular resistance. By achieving this specific reduction in resistance, the medication generally helps to ease the workload on the heart and manage conditions associated with restricted blood flow, such as when treating high blood pressure.

Regulatory References

  1. National Center for Biotechnology Information

What side effects are possible with Posipin?

Possible Side Effects and Safety Information

The safety profile of Posipin (Nifedipine) is officially documented by government regulatory agencies, classifying potential adverse reactions by frequency and the system-organ class affected. These classifications are strictly derived from clinical trial and post-marketing data, primarily reflecting the drug's potent vasodilatory action.

Frequency Classification of Documented Adverse Reactions

Adverse reactions are grouped according to their reported incidence:

Classification System-Organ Classes Affected Example Adverse Reactions
Very Common General, Nervous, Vascular Peripheral oedema, Headache
Common Cardiac, Vascular, General Flushing, Dizziness, Palpitations, Constipation
Uncommon Nervous, Vascular, Gastrointestinal Hypotension, Vertigo, Dyspepsia
Rare Blood, Lymphatic, Oral Leukopenia, Agranulocytosis, Gingival hyperplasia

Serious Adverse Reactions and Safety Restrictions

Officially documented serious adverse reactions include rare instances of increased angina or myocardial infarction, which have been reported, particularly during the initiation of treatment or following a dosage increase in patients with severe coronary artery disease. Excessive, poorly tolerated hypotension is also noted as a possible event.

Specific safety restrictions include formal contraindications for use in conditions such as cardiogenic shock, and caution is required for individuals with hepatic impairment (liver issues) due to potential changes in drug exposure. The label notes that certain effects, such as hypotension, are more likely to occur during initial titration or subsequent upward dosage adjustments.

Overdose and Emergency Response

Posipin Overdose and When to Seek Help

Posipin (a type of calcium channel blocker) overdose can be life-threatening and requires immediate medical intervention. Symptoms can vary significantly depending on the amount ingested and whether the formulation was immediate- or sustained-release, with onset potentially delayed by several hours for extended-release products. Initial signs may be non-specific, such as dizziness or fatigue, but can rapidly progress to severe cardiovascular complications.

Overdose Symptoms

Potential symptoms of a Posipin overdose reflect its mechanism of action on the heart and blood vessels. These often include:

System Common Manifestations
Cardiovascular Profound low blood pressure (hypotension), slow heart rate (bradycardia), irregular heartbeat, or even cardiac arrest.
Neurological Confusion, drowsiness, decreased level of consciousness, or stupor.
Other Nausea, vomiting, and a significant increase in blood sugar (hyperglycemia).

When to Seek Immediate Help

Call for emergency medical services immediately if you or someone else has taken more than the prescribed dose of Posipin, even if no symptoms are currently apparent. Overdose is a medical emergency. Do not wait for symptoms to worsen.

Immediate medical care for Posipin overdose typically involves monitoring vital signs, gastrointestinal decontamination (such as activated charcoal, if appropriate), and administering intravenous fluids and medications to manage severe effects. Specific treatments often include calcium salts, glucagon, and high-dose insulin therapy.

Therapeutic Uses of Posipin

What Posipin Treats: Main Uses and Benefits

Posipin is generally used to help manage conditions presenting with systemic imbalance related to the circulatory system, focusing on areas where symptoms related to heightened physiological activity are relevant. The medication is primarily applied in addressing three distinct symptom and condition clusters, including high blood pressure (hypertension), angina pectoris (chest pain), and Raynaud's phenomenon.


This medication is applied across conditions marked by chronic, sustained high blood pressure, and is relevant in situations where symptoms linked to organ-specific functional stress may occur. The primary therapeutic benefit plays a role in managing blood pressure, which may be relevant for managing symptoms linked to organ-specific functional stress over time.

Applied across domains where additional symptomatic support is needed, Posipin is used in symptom-driven clinical presentations to address symptom clusters that may become intense or disruptive. The therapeutic support provided may assist in managing the frequency and intensity of episodic manifestations, offering symptomatic relief that helps patients cope more steadily with difficult manifestations. For those with peripheral vascular issues, the drug is relevant for easing symptoms that cluster into patterns of pain and severe cold sensitivity in the extremities.


Quick Fact: Support for Vascular Symptoms

This medication is commonly used to help manage symptoms related to heightened physiological activity and localized discomfort that interferes with daily functioning. It is relevant when supportive symptom management is appropriate for conditions like angina and cold-induced vasospastic attacks.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Posipin (Nifedipine)?

Eligibility to use Posipin is determined by official regulatory bodies, primarily based on pre-existing medical conditions, hypersensitivity, and age.

Contraindicated Populations (Must Not Use)

Condition/Population Status
Hypersensitivity Contraindicated (to Nifedipine or any Dihydropyridine)
Acute Cardiac Events Contraindicated (e.g., Cardiogenic Shock, Unstable Angina, or use within one month of Myocardial Infarction)
Drug Interaction Contraindicated (with strong CYP3A4 inducers like Rifampicin)

Restricted and Non-Recommended Populations

Population/Condition Restriction
Pediatric Patients Not Recommended (Safety and efficacy not established in those under 18)
Pregnancy/Lactation Contraindicated in early pregnancy; Not Recommended during breastfeeding
Hepatic Impairment Requires Careful Monitoring; dose reduction may be necessary
Severe Hypotension Requires Special Caution due to risk of further blood pressure drop

Use is generally approved for adults 18 years and over for labeled indications. Patients with renal impairment typically do not require dosage adjustment. Immediate-release formulations should generally be avoided in older adults.

What should I know about interactions with other medicines?

Posipin (Nifedipine) Interactions with other medicines and products are primarily defined by pharmacokinetic modulation and pharmacodynamic effects, as described in official regulatory documents.

Interaction Category Specific Substance/Class Official Constraint
Contraindicated Rifampicin, St. John's Wort Prohibited co-administration due to significant loss of Nifedipine exposure resulting from CYP3A4 enzyme induction.
Dietary Restriction Grapefruit or Grapefruit Juice Must be avoided completely; significantly increases Nifedipine plasma levels by inhibiting intestinal CYP3A4.

Co-administration with other medications that inhibit the CYP3A4 enzyme, such as certain antibiotics (Clarithromycin) and antifungals (Ketoconazole), increases Nifedipine exposure, which necessitates clinical monitoring. Conversely, co-administration with other agents that induce CYP3A4 (e.g., Phenytoin) may reduce Nifedipine effectiveness. A pharmacodynamic interaction risk exists with other antihypertensive agents and PDE5 inhibitors, leading to an additive hypotensive effect. Furthermore, Nifedipine officially reduces the clearance of drugs such as Digoxin and the immunosuppressants Tacrolimus and Cyclosporine, resulting in elevated plasma concentrations of these co-administered agents. The extended-release formulation is not recommended in patients with moderate or severe hepatic impairment due to altered drug clearance and increased bioavailability.

Mechanism of Action

Selective Blockade of Vascular Calcium Channels

Posipin's pharmacodynamic action is governed by its focused activity as a Calcium Channel Blocker, which interrupts a fundamental biological signal necessary for muscle contraction. The drug exerts its primary mechanism through highly specific antagonism of the L-type Voltage-Dependent Calcium Channel (Cav1.2) found on arterial smooth muscle cells. This binding action physically blocks the channel, inhibiting the influx of extracellular calcium ions (Ca^2+) required to initiate muscle contraction. This mechanism modifies the early molecular steps that determine the overall tone of the blood vessels.

Modulation of Arterial Smooth Muscle Tone

By preventing calcium entry, Posipin disrupts the Excitation-Contraction (E-C) Coupling pathway, which leads directly to the relaxation of arterial walls. This targeted myorelaxation, known as vasodilation, profoundly lowers the resistance within the circulation. This mechanism results in a reduction in smooth muscle tone within the systemic vasculature by reducing wall tension.

Regulation of Systemic Vascular Resistance

The resulting vasodilation reduces the Systemic Vascular Resistance (SVR), or Afterload, which is the total collective friction the heart works against to pump blood. This physiological adjustment results in a reduction of the afterload (myocardial wall stress) placed on the heart, leading to systemic changes that are a direct physiological consequence of the drug's action. This peripheral action is constrained by a minimal effect on venous vessels and the potential for a compensatory Reflex Tachycardia.

Dosage and Administration Information

Posipin (Nifedipine) is administered exclusively by the oral route, available in two primary forms: Immediate-Release (IR) capsules and Extended-Release (ER) tablets. The type of preparation dictates the official dosing frequency and administration pattern.

The Extended-Release tablet is generally prescribed for once-daily (QD) administration. Standard initial doses typically range from 30 mg to 60 mg, with authorized maintenance dose ranges extending up to 90 mg or 120 mg daily, depending on the specific formulation. The Immediate-Release capsule follows a different schedule, requiring administration multiple times daily, commonly three or four times, with an initial dose often set at 10 mg. Dose adjustments are made gradually, usually over a period of seven to fourteen days.

Official instructions for the ER tablet require that it be swallowed whole; the tablet must not be chewed, crushed, or divided. During the entire course of therapy, patients must avoid consuming grapefruit juice, as this can affect the proper utilization of the medicine.

Posipin is designated for long-term, continuous therapy. Treatment must not be stopped abruptly; instead, the dosage must be gradually reduced (tapered) to adhere to the procedural protocol for discontinuation. Furthermore, dose modifications may be necessary for individuals with severe hepatic impairment, and the medicine’s use in pediatric patients is not established for approved adult indications.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes the published research regarding the combination drug. It details what studies examined, investigated, or evaluated without interpreting results or offering patient recommendations.

Key Study Findings

Research has explored whether the drug may shorten the duration and severity of the common cold. Studies investigated whether the drug was associated with a reduction in pain and fever. Findings regarding clinical relevance and optimal timing of use were mixed.

Reduction in Cold Duration

  • Initial studies: Early research explored whether the drug was associated with a reduction in total illness duration, typically by 1–2 days.
  • Larger trials: Subsequent larger trials did not consistently replicate these findings, suggesting the effect may be limited or difficult to observe.

Symptom Management

  • Fever and Pain: Most studies focused on evaluating the drug’s potential effect on reducing fever and general body aches. The results generally showed that participants reported a decrease in the intensity of these symptoms during the course of the study.
  • Congestion: Research examined whether the active ingredients were associated with changes in nasal airflow and congestion severity. Outcomes suggested potential temporary relief.

The Combination Effect

Research has explored whether the combined ingredients may have a differential effect on symptom resolution compared to single-ingredient treatments. Evidence remains limited on whether the combination provides a significant clinical advantage compared to either ingredient used alone.

  • Synergy: Studies have not established a clear link between the timing of use and clinical outcomes.
  • Patient Experience: Studies have not yet established a clear role for the combination drug in symptom management.

Safety Profile (What was Studied)

Studies focused on evaluating the incidence of common adverse effects such as drowsiness and gastrointestinal upset.

  • Common Adverse Effects: Data collected from trials indicated that the most frequently reported side effects included mild sedation and nausea.
  • Contraindications: Research did not specifically evaluate the safety of this combination for all populations.

Frequently Asked Questions (FAQ)

Common questions about Posipin (FAQ)


Q: What happens if I miss a dose of Posipin?

Official patient information notes that if a dose is forgotten, it may be taken as soon as it is remembered. If it is close to the time for the next scheduled dose, professional guidance suggests skipping the missed dose to maintain the correct schedule.


Q: How quickly should I expect to notice Posipin working?

According to official pharmacokinetics data, the extended-release form typically reaches a stable concentration level in the blood approximately six hours after the first dose. This stability is generally maintained over the 24-hour dosing interval.


Q: Can Posipin cause changes to my weight?

Official information indicates that rapid weight gain is a possible adverse effect. This reported change is frequently related to fluid retention, known as peripheral edema, which is listed in official documents as a very common side effect.


Q: Is there a list of foods or drinks to avoid while taking Posipin?

Official instructions emphasize the need to avoid grapefruit and grapefruit juice because they can significantly affect the amount of medication in the body. Additionally, following a low-salt or low-sodium diet may be necessary for the management of the underlying condition.


Q: Do I need to take Posipin at a specific time of day?

The extended-release tablet is generally recommended to be taken once daily on an empty stomach. The labeling states that it should be taken apart from meals to ensure proper absorption. The immediate-release capsule has a different multiple-times-daily schedule.


Q: What are the known interactions between Posipin and supplements?

The herbal product St. John’s Wort is an official contraindication, as it significantly reduces the drug's effectiveness. Other supplements, such as multivitamins with minerals, are also noted as potentially affecting the medication’s action.


Q: Does Posipin affect blood pressure or heart rate?

Yes, the medication functions to reduce blood pressure, and this action may result in hypotension (low blood pressure). The label also notes the potential for a compensatory increase in heart rate, known as reflex tachycardia, due to the widening of the blood vessels.


Q: What should I do if I feel dizzy after taking Posipin?

Official patient information notes that dizziness and lightheadedness may occur, particularly when a person changes position suddenly, such as when standing up from sitting or lying down. Patients are advised to use caution when performing these movements to assess their response to the medication.


Q: Will Posipin affect my ability to drive or operate machinery?

Official warnings advise using caution due to the possibility of side effects like dizziness, lightheadedness, and mild sedation. Patients may need to avoid driving or operating hazardous machinery until they understand how the medication affects them.


Q: Are there specific symptoms that mean Posipin is not right for me?

Official sources indicate that symptoms like significant swelling of the face or extremities, tingling sensations, or unusual weight changes should be reported promptly to a healthcare provider. These occurrences may signal a need for professional medical evaluation.


Q: Can teenagers or children take Posipin?

Official information states that the safety and efficacy of the medication have not been established in the pediatric population, which includes individuals under 18 years of age. Therefore, its use is generally not recommended for this age group for the approved adult conditions.


Q: Can Posipin cause stomach upset or nausea?

Documented adverse reactions include gastrointestinal upset, such as belching, indigestion, and nausea. These are included in the official safety profile derived from clinical data.


Q: Does my diet impact how well Posipin works?

Dietary factors can impact how the medication works. Grapefruit products are noted as requiring complete avoidance because they can significantly affect the amount of medication in the body. Additionally, following a prescribed low-salt or low-sodium diet is an important part of managing the conditions the drug is used to treat.


Q: Is the long-term use of Posipin studied?

While the medication is intended for long-term, continuous therapy, official clinical study information indicates that data on sustained effectiveness and long-term safety evaluation may be limited in specific patient populations beyond short-term trials.


Q: Is Posipin used for prevention or for treatment?

Official product information describes the drug's use for the treatment of chronic conditions such as hypertension and stable angina. Its goal is to manage symptoms and reduce the risk of associated future cardiovascular events.


Q: Does Posipin help with anxiety or stress?

The medication is a calcium channel blocker whose approved general purpose is the management of cardiovascular conditions like high blood pressure and angina. It is not indicated for the treatment of anxiety or stress.


Q: If Posipin isn't working for me, what should I expect next?

If the desired results are not achieved, dosage adjustments may be necessary. Official guidance indicates that doses can be increased gradually over a period of seven to fourteen days under professional supervision. If discontinuation is necessary, the dose must be gradually reduced.


Q: What is the brand name and the generic name for Posipin?

The active ingredient, or generic name, of this medication is Nifedipine. Posipin is the brand name used for the active ingredient, Nifedipine.


Q: Is it normal to feel a mild headache when first starting Posipin?

Headache is listed as a very common documented side effect. It often occurs during the initial period of treatment or following a dose increase, and studies suggest the severity of this side effect may lessen over time as the body adjusts.


Q: Does Posipin interact with common pain relievers like Tylenol or Advil?

Official drug interaction databases currently report no specific interaction between this medication and common over-the-counter pain relievers such as acetaminophen (Tylenol). However, it is always essential to disclose all medications to a healthcare provider.


Q: Can I drink alcohol while taking Posipin?

Official warnings note that alcohol (ethanol) may have an additive effect in lowering blood pressure when taken with this medication. It may also worsen other side effects, such as dizziness and headache.


Q: Is Posipin associated with mood changes or depression?

Mood changes have been noted in the official list of documented adverse effects for this medication. If this is a concern, it should be discussed with a healthcare provider.


Q: How long does treatment with Posipin usually last?

The medication is classified and prescribed for long-term, continuous therapy, as it is used for the ongoing management of chronic conditions such as high blood pressure.


Q: What kind of studies support the use of Posipin?

The medication's approved uses are supported by a foundation of controlled clinical trials. These studies have investigated its use in reducing blood pressure and managing conditions like chronic stable angina.


Q: Is there a generic version of Posipin available?

Yes, generic formulations of the active ingredient, Nifedipine, are approved by regulatory bodies like the FDA and are widely available.


Q: How does Posipin affect the liver?

Official documents note that rare, usually transient, elevations of certain liver enzymes have been observed in studies. The relationship of these changes to the medication is considered uncertain in most cases.


Q: Why is Posipin only available by prescription?

The medication is classified as a prescription-only drug because its use requires professional supervision. This is necessary for managing the dosage, monitoring for side effects, and overseeing potential drug interactions.


Q: When was Posipin first approved for use?

The active ingredient, Nifedipine, was patented in 1967 and was first approved for use in the United States by the FDA in 1981.


Q: Are there any required tests (like bloodwork) while taking Posipin?

While routine blood tests are not universally required, official documents emphasize the need for close monitoring of blood pressure and heart rate. This is especially important when starting treatment or when co-administered with certain other medications.


Q: Is there an official patient leaflet for Posipin I can read?

Yes, authoritative sources like the NIH and FDA provide official patient information and prescribing leaflets (e.g., DailyMed label). These resources can be accessed online or provided by a pharmacist.


Q: Can I take Posipin with my daily vitamins?

Official drug interaction information suggests that co-administration with multivitamins containing minerals may potentially decrease the effects of this medication.


Q: What is the difference between Posipin and its other forms (e.g., tablet vs. capsule)?

The Immediate-Release (IR) capsule is typically taken multiple times daily. The Extended-Release (ER) tablet is taken once daily on an empty stomach and must be swallowed whole; it should not be chewed, crushed, or divided.


Q: What happens if I take Posipin with food versus on an empty stomach?

The extended-release tablet is officially recommended to be taken on an empty stomach. The labeling states that it should be taken apart from meals to ensure proper absorption, as taking it with food can delay the absorption of the drug.

How should Posipin be stored and disposed of?

How to Store and Dispose of Posipin?

The storage and handling of Posipin (Nifedipine oral preparations) must strictly follow conditions established by regulatory labeling to maintain stability and ensure safety.


Official Storage Conditions

The medication must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F to 77 F). The product must be protected from light and excess moisture, requiring that the medicine remain in its original container and be kept tightly closed. Tablets or capsules should be kept in their original packaging until the time of use.

Child Safety and Disposal

Posipin must be stored out of the sight and reach of children.

To dispose of unused or expired medicine, patients should utilize an official drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance, sealed in a container, and discarded in the household trash; the medicine must not be flushed down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Posipin found in:

A-Z Index: